Publications

09 Jul 2001
Research & Ideas

Does Misery Love Companies? How Social Performance Pays Off

guiding the conduct of the business enterprise. . . . The world cries out for repair. While some people in the world are well off, many more live in misery. Ironically, the magnitude of the problem defies easy recognition. With the global... View Details

Keywords: by Joshua D. Margolis & James P. Walsh

December 2007 (Revised July 2009)
Case

Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?

GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details

Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe

30 Apr 2012
Research & Ideas

India’s Ambitious National Identification Program

them." In July 2009, the Indian government invited Nandan Nilekani, cofounder and cochairman OR cofounder and former CEO of the global technology services firm Infosys and a champion of private-sector entrepreneurship, to lead the... View Details

Keywords: by Dina Gerdeman

04 Apr 2017
First Look

First Look at New Research, April 4

https://www.hbs.edu/faculty/Pages/item.aspx?num=52469 2017 Ethical Capitalism: Shibusawa Eiichi and Business Leadership in Global Perspective Gapponshugi in Global Perspective: Debating the Responsibility of... View Details

Keywords: Sean Silverthorne

January 2023
Supplement

Apple: Privacy vs. Safety (B)

By: Henry McGee, Nien-hê Hsieh and Christian Godwin

In 2020, as the COVID-19 pandemic swept across the globe, Apple and Google partnered to develop a contact tracing application that would collect information about users infected with the disease and notify those who they had been in contact with. While Apple/Google’s... View Details

19 Jun 2012
First Look

First Look: June 19

312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010... View Details

Keywords: Sean Silverthorne

02 Dec 2009
What Do You Think?

Should Immigration Policies Be More Welcoming to Low-Skilled Workers?

dismantled a lot of trade barriers, which has led to global prosperity. The only big barrier remaining is movement of humankind to regions which offer better prospects." A number of respondents took issue with this. Some equated... View Details

Keywords: by Jim Heskett

February 1994 (Revised May 1999)
Case

Manville Corp. Fiber Glass Group (C)

By: Lynn S. Paine and Sarah Gant

Manville Corp.'s senior managers are surprised when Japanese government officials advise them not to go forward with their plan to add a cancer warning label to diatomaceous earth (DE) products sold in Japan. The International Agency for Research on Cancer has ruled... View Details

Keywords: Management Teams; Ethics; Conflict of Interests; Health; Safety; Cross-Cultural and Cross-Border Issues; Policy; Japan

05 Dec 2005
What Do You Think?

Is Growth Good?

growth targeted. In fact, many kinds of growth offer great returns while requiring little or none of the world’s resources, therefore having seemingly few limits. Fran Henry makes the case for economic growth when she says, "According to the World View Details

Keywords: by James Heskett

March 1993
Supplement

Burroughs Wellcome and AZT (C)

By: Willis M. Emmons III

Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details

Keywords: Health Pandemics; Multinational Firms and Management; Financial Statements; Pharmaceutical Industry; United States

April 2024 (Revised July 2024)
Case

Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs

By: Joseph L. Badaracco, Tom Quinn and John Schultz

Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details